| Feb 17, 2026 | NOT A HOTEL | $65.8M Debt / Series C | — | 長澤 啓, Rava Partners, SuMi TRUST Innovation Investment |
| Feb 11, 2026 | ZAST.AI | $6.0M Series A | Hillhouse Capital Group | — |
| Feb 5, 2026 | Angitia Biopharmaceuticals | Angitia Biopharmaceuticals Series D | Frazier Life Sciences, Venrock, Venrock Healthcare Capital Partners, Frazier Life Sciences | Bain Capital Life Sciences, Biotechnology Value Fund, BlackRock, Elikon Venture, Hillhouse Investment, Janus Henderson Investors, Legend Capital, Logos Capital, Morningside, OrbiMed, RA Capital Management, TF Capital, Wellington Management, Yonghua Capital, 3H Health Investment, Ascenta Capital, BlackRock, Janus Henderson Investors, RA Capital Management |
| Feb 4, 2026 | Third Arc Bio | Third Arc Bio Series A Extension | Andreessen Horowitz, Jorge Conde, Jorge Conde | AbbVie Ventures, abrdn, BVF Partners, Freepoint Capital Group, Galapagos, Marshall Wace, Omega Funds, T. Rowe Price Associates |
| Jan 29, 2026 | Tenpoint Therapeutics Ltd | $235.0M Debt / Series B | British Business Bank, EQT Nexus, Hillhouse Capital Group, Agustin Mohedas | Advent France Biotechnology, Eight Roads Ventures, F-Prime Capital, Hercules Capital, Qiming Venture Partners USA, Sofinnova Partners, Wille Finance |
| Jul 1, 2024 | Third Arc Bio | $170.0M Series A | Vida Ventures, Cormorant Asset Management, Hillhouse Capital Group | Sofinnova Investments, AbbVie Ventures, abrdn, BVF Partners, Foresite Capital, Freepoint Capital Group, Goldman Sachs, Janus Henderson Investors, Logos Capital, Marshall Wace, Francesco Draetta, Loretta Tse, T. Rowe Price Associates |
| Jan 1, 2024 | Orange Dental | $130.0M Series B | Oceanpine Capital, OrbiMed | 3W Capital, Adjuvant Capital, AIHC Capital, Eight Roads Ventures, F-Prime Capital, Haitong International, MSA Capital, Superstring Capital |
| Apr 20, 2023 | Noah Medical | $150.0M Series B | Prosperity7 Ventures, SoftBank Vision Fund | 1955 Capital, AME Cloud Ventures, Hongshan Capital Group (Sequoia Capital China), LYFE Capital, ShangBay Capital, Sunmed Capital, Tiger Global, Uphonest Capital |
| Jan 11, 2023 | Hystar | $26.0M Series B | Charlie Clark, Toshihiro Hayashi | Hans Maenhout, Firda, Nippon Steel Trading, SINTEF Ventures, Trustbridge Partners |
| Jan 6, 2023 | Chint New Energy | $218.6M Series B | — | — |
| Feb 1, 2022 | Fenbeitong | $140.0M Series C | DST Global | Alumni Ventures, Glade Brook Capital Partners, IDG Capital, Lightbank, Lightspeed Venture Partners, Ribbit Capital, David Dubick, BitRock Capital, D1 Capital Partners, Emergence Capital, Saudi Aramco, Stau, Whale Rock Capital |
| Jan 13, 2022 | Yahaha | $50.0M Other Equity | 5Y Capital, Coatue, Hillhouse Capital Group | BAI Capital, Bilibili, Xiaomi, ZhenFund |
| Aug 1, 2021 | VanMoof | $130.0M Series C | Haoyu Shen | Balderton Capital, Gillian Tans, Felix Capital, Norwest Venture Partners, TriplePoint Capital |
| Jul 27, 2021 | MicroPort CRM | $150.0M Series C | Hillhouse Capital Group, MicroPort | CICC Capital, Country Garden Venture Capital, L Squared Capital Partners, Wanhui Capital, YongRong Asset Management |
| Jul 19, 2021 | Nature's Fynd | $350.0M Series C | Angela Du | Al Gore, Bill Gates, Jeff Bezos, 1955 Capital, ADM, Balyasny Asset Management, Blackstone, Breakthrough Energy Ventures, Danone Manifesto Ventures, EDBI, Hongkou, SK |
| Jul 1, 2021 | Nobell Foods | $75.0M Series B | — | Breakthrough Energy Ventures, Helium-3 Ventures, Dan Siroker, James Park, Julie Zhuo, Matt Bellamy, Matthew Bellamy, AgFunder, Andreessen Horowitz, Fifty Years, Robert Downey Jr., Germin8 Ventures, Mission Bay Capital, Pear VC, Unovis Asset Management |
| Jun 30, 2021 | ArriVent Biopharma | $150.0M Series A | Hillhouse Capital Group | Lilly Asia Ventures, Lyra Capital, Octagon Capital, OrbiMed, Zoo Capital |
| Jun 23, 2021 | Exegenesis Bio | $50.0M Series B | Hillhouse Capital Group | CPE, Lake Bleu Capital, LYFE Capital, Temasek Holdings |
| Jul 7, 2020 | MicroPort CRM | $105.0M Series B | Hillhouse Capital Group | MicroPort, Yunfeng Capital |
| Mar 1, 2020 | Yuanfudao | $1.0B Series G | Hillhouse Capital Group, Tencent | Griffin Gaming Partners, IDG Capital, Boyu Capital |
| Feb 18, 2019 | Hetao101 | $177.3M Series A | Hillhouse Capital Group | Source Code Capital, XVC |
| Jan 3, 2019 | CarDekho | $110.0M Series C | CapitalG, Hillhouse Capital Group, Shailesh Lakhani | Ratan Tata, Axis Bank, Dentsu, HDFC Bank, Times Internet |
| Nov 1, 2018 | NextCure | $93.0M Series B | Michael Yi, Stella Xu | 5AM Ventures, Access Biotechnology, Canaan Partners, Connecticut Innovations, Endeavor Venture Funds, Nextech Invest, OrbiMed, RA Capital, Alexandria Venture Investments, ArrowMark Partners, Bay City Capital, Canaan Partners, Lilly Asia Ventures, NS Investment, Pfizer, Ping An Ventures, Sofinnova Ventures, Surveyor Capital, Taiho Ventures |
| Jul 30, 2018 | Omniome | $60.0M Series B | Decheng Capital, Hillhouse Capital Group | Altitude Life Science Ventures, ARCH Venture Partners, Biomatics Capital, Domain Associates, Lam Capital, Nan Fung Life Sciences |
| Jul 1, 2018 | Airwallex | $80.0M Series B | Neil Shen, Tencent | 5Y Capital, Addition, Blackbird Ventures Australia, FPV Fund, King Goh, Index Ventures, Kleiner Perkins, Main Sequence Ventures, Salesforce Ventures, Sapphire Ventures, Sequoia Capital China, Square Peg Capital, Central Capital Ventura, Li Ka-shing |
